Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- American (1)
- Apparel (1)
- Average (1)
- Beauty (1)
- Business (1)
-
- Culture (1)
- Curvy (1)
- DMD (1)
- Duchenne Muscular Dystrophy (1)
- Eteplirsen (1)
- Fashion (1)
- Fashion Week (1)
- Fat (1)
- Fat and Fit (1)
- Female (1)
- Fit (1)
- Full-Figured (1)
- Full-Figured Fashion Week (1)
- Health and Science (1)
- Healthcare (1)
- Industry (1)
- Large (1)
- Mercedes-Benz Fashion Week (1)
- Metabolically Healthy Obesity (1)
- Metabolically Obese (1)
- Muscle disease (1)
- Muscular dystrophy (1)
- New York City (1)
- New York Fashion Week (1)
- Obesity (1)
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
The Sixty-Six Percent, Natalie Abruzzo
The Sixty-Six Percent, Natalie Abruzzo
Capstones
The Sixty-Six Percent represent the percentage of women in the U.S. who are overweight. They are regarded as full-figured or “plus” size in the world of women’s apparel. Even though more than half of American women wear a “plus” size - size 14 and up - designs for these women account for a fraction of women’s apparel - Only 37% of women's wear is plus-size.
The Sixty-Six Percent is coming at an important time in a broader conversation about de-stigmatizing what it means to be a plus-size woman in America. Fat shaming has become taboo and mainstream media as well …
Special Muscles, Annamaria C. Scaccia
Special Muscles, Annamaria C. Scaccia
Capstones
Special Muscles is a documentary that explores living with Duchenne muscular dystrophy, a fatal degenerative disease that weakens the muscles at an aggressive rate. The film will give an uncensored look at how one family copes with inevitability of the disease and their journey chasing a promising experimental cure.
Special Muscles follows 7-year-old Pietro Scarso and his family as they face the challenges, complications and promise of treating Pietro’s progressive muscle disorder. The film travels from New York to Los Angeles to Philadelphia to document the Scarso family’s race against time as Pietro undergoes a 96-week clinical trial for Eteplirsen, …